Systemic injection of antigen is one of the approaches that reproducibly induces effective
antigen-specific hyporesponsiveness. Here, Roland Liblau and colleagues discuss the
cellular and molecular bases of such tolerance, review the current use of this therapeutic
strategy in experimental organ-specific autoimmune diseases and analyse what steps are
necessary to make this approach suitable for clinical use.